Tag: Research Achievement Award

Asif Khan | Social Sciences | Best Researcher Award

Published on by World Science Awards

Dr. Asif Khan | Social Sciences | Best Researcher Award

Postdoctoral Fellow at Hainan University, China 

Dr. Asif Khan is a distinguished academic and legal expert, currently serving as Director at the Faculty of Law, University of Sialkot, Pakistan. He holds a Ph.D. in International Laws from Zhengzhou University, China, with a focus on digital trade under WTO agreements. Dr. Khan’s research interests encompass international human rights, environmental protection, and the integration of technology and climate change within international law. His extensive academic career includes roles as Assistant Professor and Lecturer at various universities, where he has taught subjects such as International Humanitarian Law and Environmental Law. Dr. Khan is also a practicing lawyer and has been involved in numerous research projects, including those on legal issues related to Pakistan-China trade and environmental law. His significant contributions to legal scholarship are reflected in his publications in prestigious journals and his active role in editorial and research societies.

Profile

Education

Asif Khan holds a Ph.D. in International Laws from Zhengzhou University, China (2019-2023), where he focused on digital trade under WTO Agreements. His academic journey includes an LL.M from International Islamic University-Pakistan (2016-2018) with a thesis on autonomous weapons and international humanitarian law, and an LL.B Hons from Abdul Wali Khan University, Pakistan (2010-2015), exploring the impact of divorce on juvenile crime and child labor.

Professional Experience

Dr. Khan’s academic career includes roles as Assistant Professor at the University of Sialkot, Pakistan, and Lecturer at Zhengzhou University, China, where he has taught subjects like International Humanitarian Law and Environmental Law. His administrative experience includes directing the Faculty of Law at the University of Sialkot and founding the Traditional Journal of Law & Social Science. Additionally, he has extensive legal practice experience as a lawyer and legal advisor, representing clients and providing legal counsel in various contexts.

Research Interest

Dr. Khan’s research focuses on international law, particularly in areas like human rights, environmental protection, and the intersection of international law with emerging issues such as technology and climate change. His work aims to refine global legal frameworks and address international challenges.

Research Skills

Dr. Khan’s skills include comprehensive legal research, writing, and analysis. He has proficiency in developing and managing research projects, contributing to high-impact publications, and engaging in academic and policy discussions on international law.

Research Contributions

Dr. Khan has made significant contributions through various research projects, including studies on legal issues related to Pakistan-China Free Trade Agreements and environmental law. His publications cover a broad spectrum, from digital trade and artificial intelligence to environmental sustainability and human rights.

Geographic Impact

His research has a global impact, particularly in the context of international trade laws, environmental regulations, and human rights issues. By addressing legal challenges across different regions, his work influences global legal practices and policies.

Collaborative Efforts

Dr. Khan has collaborated with various institutions and researchers, including international universities and journals. His role as editor and sub-editor in several research journals highlights his engagement in the global academic community.

Applied Research

Dr. Khan’s research is applied in understanding and addressing legal challenges in digital trade, environmental sustainability, and international humanitarian law. His work contributes to practical solutions and policy recommendations in these fields.

Specific Projects and Publications

His notable projects and publications include a Ph.D. thesis on digital trade regulations, LL.M thesis on autonomous weapons, and numerous articles in prestigious journals like Heliyon, International Journal of Environmental Research and Public Health, and various Pakistani journals. His work covers critical areas such as e-commerce regulations, human rights, and environmental jurisprudence.

Environmental Health

Dr. Khan’s research includes examining environmental law, focusing on how legal frameworks can address environmental issues and promote sustainability. His publications and projects reflect a commitment to advancing environmental health through legal perspectives.

Vector Control

Although not explicitly mentioned, Dr. Khan’s focus on environmental protection and sustainability may intersect with vector control efforts, especially in the context of legal frameworks and policy development for public health.

Parasitology and Infectious Diseases

While Dr. Khan’s primary focus is on international law rather than parasitology or infectious diseases, his research on environmental issues and human rights could indirectly contribute to discussions on public health and disease control.

Awards and Recognition

Dr. Khan’s work is recognized through his publications in top-tier journals and his editorial roles. His contributions to legal scholarship and practice have garnered acknowledgment in academic and professional circles.

Conclusion

Dr. Asif Khan’s extensive academic and professional background, combined with his impactful research and contributions to international law, make him a strong candidate for the Research for Best Researcher Award. His work addresses critical global issues, from digital trade and environmental protection to human rights, demonstrating a commitment to advancing legal and policy frameworks on an international scale.

Publications Top Notes

  1. Composite antibacterial hydrogels based on two natural products pullulan and ε-poly-L-lysine for burn wound healing
    • Authors: Cui, W., Gong, C., Liu, Y., Yang, Z., Yang, J.
    • Year: 2024
  2. A novel isoquinoline alkaloid HJ-69 isolated from Zanthoxylum bungeanum attenuates inflammatory pain by inhibiting voltage-gated sodium and potassium channels
    • Authors: Wang, L., Hao, H., Meng, X., Zheng, Y., Yang, J.
    • Year: 2024
  3. Chemical constituents from Notopterygium incisum and their anti-neuroinflammatory activity
    • Authors: Ma, L.-M., Shi, J.-T., Chai, T., Wang, J., Yang, J.-L.
    • Year: 2024
  4. A comprehensive review of the molecular and genetic mechanisms underlying gum and resin synthesis in Ferula species
    • Authors: Karimi, M.R., Jariani, P., Yang, J.-L., Naghavi, M.R.
    • Year: 2024
  5. Rapid evaluation of PHD2 inhibitory activity of natural products based on capillary electrophoresis online stacking strategy
    • Authors: Zhang, Y., Sang, C.-Y., Wang, X.-R., Wang, W.-F., Yang, J.-L.
    • Year: 2024
  6. Sesquiterpenes from Inula macrophylla and their anti-neuroinflammatory activity
    • Authors: Ma, R., Komilov, B., Wang, C.-B., Ha, W., Shi, Y.-P.
    • Year: 2024
    • Citations: 1
  7. Sesquiterpene coumarins from Ferula sinkiangensis and their anti-pancreatic cancer effects
    • Authors: Wang, J.-L., Sang, C.-Y., Wang, J., Zhao, Y.-M., Yang, J.-L.
    • Year: 2023
    • Citations: 2
  8. Labdane diterpenoids from Lagopsis supina and their anti-neuroinflammatory activity
    • Authors: Wang, K., Shi, J.-T., Zhang, Y., Wang, J., Yang, J.-L.
    • Year: 2023
    • Citations: 1
  9. Gypenoside-14 Reduces Depression via Downregulation of the Nuclear Factor Kappa B (NF-kB) Signaling Pathway on the Lipopolysaccharide (LPS)-Induced Depression Model
    • Authors: Jiang, Y., Cheng, X., Zhao, M., Yang, J., Zhu, L.
    • Year: 2023
    • Citations: 2
  10. Monoterpene Esters from Ferula ferulioides
    • Authors: Sobirov, S.M., Kamoldinov, K.S., Turgunov, K.K., Zhao, J., Yang, J.
    • Year: 2023

 

 

 

 

Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Published on by World Science Awards

Dr Ahmet Ozdemir | Medicinal Chemistry | Best Researcher Award

Professor Doctorate, Anadolu University ,Turkey.

Ahmet ÖZDEMİR, born on July 24, 1972, in Muğla, Turkey, is a Professor of Pharmaceutical Chemistry at Anadolu University, where he has been a faculty member since 1997. He earned his undergraduate degree in Pharmacy from Anadolu University (1990-1994), followed by an M.Sc. in Pharmaceutical Chemistry (1995-1996) and a Ph.D. in the same field (1996-2004), with research focusing on the synthesis and biological activities of novel compounds. Dr. ÖZDEMİR has held various academic positions at Anadolu University, advancing from Research Assistant to Professor. He has also served in administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School and Vice Academic Director of the Open Education Faculty’s Department of Health Administration. His research is well-regarded, earning him multiple awards, including the Anadolu University Article Performance Award and the ISIF’21 Silver Medal for his work on targeted novel triazolothiadiazine derivatives for lung cancer treatment.

Profile:

Education

Prof. Dr. Ahmet Özdemir’s educational journey began at Salihli Cumhuriyet Elementary School, where he completed his primary education from 1978 to 1983. He continued his secondary education at Salihli 50. Yıl Secondary School from 1983 to 1986, and then attended Salihli High School from 1986 to 1989, where he completed his high school education. Prof. Dr. Özdemir pursued his undergraduate studies at Anadolu University Faculty of Pharmacy, graduating in 1994. He furthered his education with a Master’s Degree in Pharmaceutical Chemistry at Anadolu University’s Graduate School of Health Sciences from 1995 to 1996, where he completed his thesis. He continued at Anadolu University for his Doctoral Degree in Pharmaceutical Chemistry, which he achieved in 2004. Additionally, he possesses intermediate proficiency in English, which complements his academic background and research expertise.

Academic Titles

Prof. Dr. Ahmet Özdemir’s academic career at Anadolu University’s Faculty of Pharmacy spans several roles and achievements. He began his journey as a Research Assistant in 1997, a position he held until 2004. Following this, he advanced to the role of Research Assistant Doctor, continuing his work at the same institution from 2004 to 2005. Dr. Özdemir was then appointed as a Lecturer from 2005 to 2007, showcasing his growing expertise in the field. His contributions were recognized with a promotion to Assistant Professor Doctor, a role he embraced from 2007 to 2010. His exceptional work led to his promotion to Associate Professor Doctor, a position he held from 2010 to 2015. Since 2015, Prof. Dr. Özdemir has served as Professor Doctor, continuing to make significant contributions to the Faculty of Pharmacy and the broader academic community.

Awards

Prof. Dr. Ahmet Özdemir has received several prestigious awards for his academic and research contributions. In 2014, he was honored with the Anadolu University Article Performance Award. His outstanding achievements continued with the Anadolu University Gold Article Performance Award and the Anadolu University Platinum Article Performance Award in 2015. He maintained a high standard of excellence, receiving the Anadolu University Article Performance Award annually from 2016 to 2018. In 2019, Dr. Özdemir was recognized with the Anadolu University Academic Success Award. His consistent performance earned him the Anadolu University Article Performance Award again in 2020. Notably, in 2021, he was awarded the ISIF’21 Silver Medal for the invention titled “Targeted Novel Triazolothiadiazine Derivatives for the Treatment of Lung Cancer” at the 6th Istanbul International Inventions Fair (ISIF’21). This award was shared with Assoc. Prof. Dr. Belgin Sever, Prof. Dr. Mehlika Dilek Altintop, and Prof. Dr. Gülşen Akalın Çiftçi.

Research Focus

Prof. Dr. Ahmet Özdemir’s research is dedicated to the field of medicinal chemistry, with a keen focus on several key areas. He specializes in the synthesis of bioactive compounds, aiming to develop novel chemical entities with potential therapeutic uses, particularly targeting antifungal and antibacterial applications. His work in pharmaceutical chemistry involves investigating the physicochemical properties of these compounds, which has significant implications for drug design and efficacy. Dr. Özdemir also explores antimicrobial agents, focusing on the synthesis and evaluation of compounds designed to combat bacterial and fungal pathogens. In the realm of drug design and development, he examines structure-activity relationships to create effective and selective pharmaceutical agents. Additionally, his contributions extend to invention and innovation, where he develops novel chemical derivatives, such as triazolothiadiazine derivatives, for potential applications in treating diseases like lung cancer.

Publications

  1. “Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy”
    • Authors: Altıntop, M.D., Ertorun, İ., Akalın Çiftçi, G., Özdemir, A.
    • Year: 2024
  2. “Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents”
    • Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
    • Year: 2024
  3. “Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents”
    • Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
    • Year: 2023
  4. “Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy”
    • Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
    • Year: 2023
  5. “A new series of hydrazones as small-molecule aldose reductase inhibitors”
    • Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
    • Year: 2023
  6. “A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer”
    • Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
    • Year: 2023
  7. “Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action”
    • Authors: Altıntop, M.D., Akalın Çiftçi, G., Yılmaz Savaş, N., Alataş, Ö., Özdemir, A.
    • Year: 2023
  8. “Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency”
    • Authors: Altıntop, M.D., Temel, H.E., Özdemir, A.
    • Year: 2023
  9. “Design, synthesis and biological evaluation of a new series of arylidene indanones as small molecules for targeted therapy of non-small cell lung carcinoma and prostate cancer”
    • Authors: Altıntop, M.D., Özdemir, A., Temel, H.E., Kaplancıklı, Z.A., Akalın Çiftçi, G.
    • Year: 2022
  10. “A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition”
    • Authors: Altıntop, M.D., Sever, B., Akalın Çiftçi, G., Alataş, Ö., Özdemir, A.
    • Year: 2022